Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome
Condition: Vascular Ehlers-Danlos Syndrome Interventions: Drug: ACER-002 (celiprolol) 200 mg BID; Drug: Placebo BID Sponsor: Acer Therapeutics Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials